Theravance Biopharma to Present Ampreloxetine Data at Autonomic SYM
Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium...
Cardiovalve Completes TARGET Enrollment for Tricuspid Valve Study
The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for...
Protaryx Medical Files 510(k) for Next-Gen Transseptal Puncture Device
Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart...
RINVOQ® Shows Superiority Over HUMIRA® in Rheumatoid Arthritis Study
AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating...
DaVita Leads New Initiatives on Middle Molecule Clearance
New U.S. data will offer first-of-its-kind evidence in patients with kidney failure DaVita today announced the...
12 NYC Pharmacies Recognized for Medicare Health Impact
Healthfirst, a leading not-for-profit health plan serving more than two million New Yorkers, today announced...